Uveal melanoma: Update and future directions

Canadian Journal of Ophthalmology

Volumn 39, Issue 4, 2004, Pages 335-342

  Rousseau, Alain P ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Metastasis; Survival; Treatment; Uveal melanoma

Indexed keywords

ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; POLYVINYL DERIVATIVE;

ANTICOAGULANT THERAPY; BRACHYTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; ENUCLEATION; HEREDITY; HUMAN; METASTASIS; RADIATION DOSE; REVIEW; TREATMENT OUTCOME; UVEA MELANOMA;

EID: 3042818024     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(04)80003-6     Document Type: Article

References (40)

1. Duke-Elder S. Diseases of the uveal tract, Vol 9 of System of ophthalmology series. London: Henry Kimpton; 1966. p. 841-6.
2. Zimmerman LE, McLean IW. An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol 1979;87(6):741-60.
3. Byrne SF, Marsh MJ, Boldt HC, Green RL, Johnson RN, Wilson DJ. Consistency of observation from echograms made centrally in the Collaborative Ocular Melanoma Study. COMS Report No. 13. Ophthalmic Epidemiol 2002;9(1):11-27.
4. Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS report no. 6. Am J Ophthalmol 1998;125(6):745-66.
5. Mortality in patients with small choroidal melanoma. COMS report no. 4. Arch Ophthalmol 1997;115:886-93.
6. Fournier GA, Saulenas AM, Seddon JM, Goitein M, Albert DM, Polivogianis L, et al. The effects of pre-enucleation irradiation on the development of metastases from intraocular Greene melanoma in hamsters. Am J Ophthalmol 1985;100:669-77.
7. Rousseau A, Boudreault G, Deschênes J, Pelletier G, Tardif Y. Malignant melanoma: radiation treatment prior to enucleation. In: Henkind P, editor. Acta: XXIV International Congress of Ophthalmology. Philadelphia: JB Lippincott Company; 1983. p. 983-7.
8. Perez CA, Marks J, Powers WE. Preoperative irradiation in head and neck cancer. Semin Oncol 1977;4:387-97.
9. Combes PF, Gary-Bobo J, Naja A, Nguyen-Saumon M, Bugat R, Mathieu A, et al. Cancers du rectum: radiothérapie pré-opératoire (344 cas). Bull Cancer 1983;70(4):317-22.
10. Rousseau AP, Deschênes J, Pelletier G, Tremblay M, Larochelle-Belland M. Effect of pre-enucleation radiotherapy on the viability of human choroidal melanoma cells. Can J Ophthalmol 1989;24(1):10-4.
11. Rousseau AP, Deschênes J, Pelletier G, Boudreault G, Tremblay M, Tardif Y, et al. Malignant melanoma: an evaluation of pre-enucleation radiotherapy [abstract]. Int Ophthalmol 1985;8(2):88.
12. Kreissig I, Rohrbach M, Lincoff H. Irradiation of choroidal melanomas before enucleation? Retina 1989;9(2):101-4.
13. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: Initial mortality findings. COMS report no. 10. Am J Ophthalmol 1998;125(6):779-96.
14. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol 1997;42(3):215-31.
15. Gragoudas ES, Seddon JM, Egan KM, Glynn RJ, Munzenrider JE, Austin-Seymour M, et al. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology 1987;94:349-53.
16. Kreissig I, Stanowsky A, Feine U. [Treatment of choroidal melanoma with a radioactive iodine 125 plaque: initial results of a pilot study.] Klin Monatsbl Augenheilkd 1987;190(5):412-9.
17. Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Munzenrider JE, Austin-Seymour M, et al. Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmology 1987;94:354-61.
18. Zur C, Caujolle JP, Betis F, Chauvel P, Gastaud P. Protonthérapie de mélanomes de la choroïde du pôle postérieur, résultats fonctionnels. Ophtalmologie 1998;12:201-4.
19. Kreissig I, Rose D, Jost B. Long-term follow-up of iodine-125 brachytherapy for choroidal melanomas. Part 1: Anatomical results and life expectancy. Eur J Ophthalmol 1993;3(3):121-6.
20. Saornil MA, Fisher MR, Campbell RJ, Robertson DM, Earle JD, Eagle RC Jr, et al. Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma. Arch Ophthalmol 1997;115:1395-400.
21. Augsburger JJ, Kleineidam M, Mullen D. Combined iodine-125 plaque irradiation and indirect ophthalmoscope laser therapy of choroidal melanomas: comparison with iodine-125 and cobalt-60 plaque radiotherapy alone. Graefes Arch Clin Exp Ophthalmol 1993;231(9):500-7.
22. Meyer-Schwickerath G. Light coagulation. St Louis: CV Mosby Co; 1960. p. 88.
23. Oosterhuis JJ, Journée-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 1995;113(3):315-21.
24. Augsburger JJ, Correa ZM, Freire J, Brady LW. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy. Ophthalmology 1998;105(9):1670-8.
25. Augsburger JJ, Schneider S, Freire J, Brady LW. Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987. Graefes Arch Clin Exp Ophthalmol 1999;237(7):558-67.
26. Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001;119(7):969-82.
27. Bechrakis NE, Scheibenbogen C, Schmittel A, Servetopoulou F, Foerster MH, Keilholz U. [Choroid melanoma. Adjuvant therapy in high risk patients and new therapy approaches in the metastatic stage.] Ophthalmologe 2002;99(5):333-7.
28. Collaborative Ocular Melanoma Study Group. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS). COMS report no. 15. Arch Ophthalmol 2001;119(5):670-6.
29. Kivelä T, Suciu S, Hansson J, Kruit WH, Vuoristo MS, Kloke O, et al. Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma. Eur J Cancer 2003;39(8):1115-20.
30. Pyrhonen S, Hahka-Kemppinen M, Muhonen T, Nikkanen V, Eskelin S, Summanen P, et al. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma. Cancer 2002;95(11):2366-72.
31. Leyvraz S, Spataro V, Bauer J, Pampallona S, Salmon R, Dorval T, et al. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 1997;15(7):2589-95.
32. Becker JC, Terheyden P, Kampgen E, Wagner S, Neumann C, Schadendorf D, et al. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Br J Cancer 2002;87(8):840-5.
33. Munzenrider JE. Uveal melanomas. Conservation treatment. Hematol Oncol Clin North Am 2001;15(2):389-402.
34. Soulières D, Rousseau A, Deschênes J, Tremblay M, Tardif M, Pelletier G. Characterization of gangliosides in human uveal melanoma cells. Int J Cancer 1991;49:498-503.
35. Tardif M, Coulombe J, Soulières D, Rousseau AP, Pelletier G. Gangliosides in human uveal melanoma metastatic process. Int J Cancer 1996;68:97-101.
36. Beliveau A, Bérubé M, Rousseau A, Pelletier G, Guérin SL. Expression of integrin a5b1 and MMPs associated with epithelioid morphology and malignancy of uveal melanoma. Invest Ophthalmol Vis Sci 2000;41:2363-72.
37. Char DH, Kroll S, Quivey JM, Castro J. Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy. Br J Ophthalmol 1996;80:117-24.
38. Melia BM, Abramson DH, Albert DM, Boldt HC, Earle JD, Hanson WF, et al. Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma I. Visual acuity after 3 years. COMS report no. 16. Ophthalmology 2001;108(2):348-66.
39. Kreissig I, Rose D, Simader E. [Iodine-125 brachytherapy of malignant melanoma. II: Long-term functional outcome.] Klin Monatsbl Augenheilkd 1996;209(1):7-12.
40. Seddon JM, Gragoudas ES, Polivogianis L, Hsieh CC, Egan KM, Goitein M, et al. Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology 1986;93:666-74.